Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jullien, D.
Right arrow Articles by Le Marchand-Brustel, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jullien, D.
Right arrow Articles by Le Marchand-Brustel, Y.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes, Vol 45, Issue 7 869-875, Copyright © 1996 by American Diabetes Association


ARTICLES

Effect of IGF-I on phosphatidylinositol 3-kinase in soleus muscle of lean and insulin-resistant obese mice

D Jullien, SJ Heydrick, N Gautier, E Van Obberghen and Y Le Marchand-Brustel
Institut National de la Sante et de la Recherche Medicale, Faculty ofMedicine, Nice, France.

Insulin and IGF-I induced a similar stimulation of glucose transport in isolated soleus muscle. These actions require phosphatidylinositol (PI) 3-kinase activation since the PI 3-kinase inhibitor, wortmannin, blocked the stimulation by both peptides. We compared IGF-I with insulin in the ability to activate PI 3-kinase in the isolated soleus muscle from lean and gold thioglucose-induced obese insulin-resistant mice. In muscles from lean mice, IGF-I and insulin were able to activate PI 3-kinase with a similar time course, the effects being maximal within 3-5 min of stimulation. However, the IGF-I concentrations required to obtain similar effects on PI 3-kinase were about 10 times higher than the corresponding insulin doses. To determine through which receptor IGF-I was activating PI 3-kinase, the ability of IGF-I to activate both its own receptor and insulin receptor was simultaneously measured. Whatever the dose used (100 or 500 nmol/l), IGF-I activated to a nearly similar extent both the tyrosine kinase activity of its own receptor and that of the insulin receptor, suggesting that IGF-I was not only activating its receptor but was also able to stimulate the insulin receptor kinase. In muscles of obese insulin-resistant mice, although the defect of PI 3-kinase activation in response to IGF-I was relatively less pronounced (45%) than in response to insulin (70%) when compared with lean mice, PI 3-kinase stimulation was still markedly altered in response to IGF-I.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
EndocrinologyHome page
K. Yoshida, K. Murao, H. Imachi, W. M. Cao, X. Yu, J. Li, R. A. M. Ahmed, N. Kitanaka, N. C. W. Wong, T. G. Unterman, et al.
Pancreatic Glucokinase Is Activated by Insulin-Like Growth Factor-I
Endocrinology, June 1, 2007; 148(6): 2904 - 2913.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Kido, J. Nakae, M. L. Hribal, S. Xuan, A. Efstratiadis, and D. Accili
Effects of Mutations in the Insulin-like Growth Factor Signaling System on Embryonic Pancreas Development and beta -Cell Compensation to Insulin Resistance
J. Biol. Chem., September 20, 2002; 277(39): 36740 - 36747.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
T. Pratipanawatr, W. Pratipanawatr, C. Rosen, R. Berria, M. Bajaj, K. Cusi, L. Mandarino, S. Kashyap, R. Belfort, and R. A. DeFronzo
Effect of IGF-I on FFA and glucose metabolism in control and type 2 diabetic subjects
Am J Physiol Endocrinol Metab, June 1, 2002; 282(6): E1360 - E1368.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
A. M. Fernandez, J. K. Kim, S. Yakar, J. Dupont, C. Hernandez-Sanchez, A. L. Castle, J. Filmore, G. I. Shulman, and D. Le Roith
Functional inactivation of the IGF-I and insulin receptors in skeletal muscle causes type 2 diabetes
Genes & Dev., August 1, 2001; 15(15): 1926 - 1934.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
T. C. Vary, L. S. Jefferson, and S. R. Kimball
Role of eIF4E in stimulation of protein synthesis by IGF-I in perfused rat skeletal muscle
Am J Physiol Endocrinol Metab, January 1, 2000; 278(1): E58 - E64.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Christopher, F. L. Hew, M. Oakley, C. Rantzau, and F. Alford
Defects of Insulin Action and Skeletal Muscle Glucose Metabolism in Growth Hormone-Deficient Adults Persist after 24 Months of Recombinant Human Growth Hormone Therapy
J. Clin. Endocrinol. Metab., May 1, 1998; 83(5): 1668 - 1681.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
K.-C. Leung, M. J. Waters, I. Markus, W. R. Baumbach, and K. K. Y. Ho
Insulin and insulin-like growth factor-I acutely inhibit surface translocation of growth hormone receptors in osteoblasts: A novel mechanism of growth hormone receptor regulation
PNAS, October 14, 1997; 94(21): 11381 - 11386.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 1996 by the American Diabetes Association.